Log in to save to my catalogue

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated...

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7275746

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

About this item

Full title

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-06, Vol.117 (22), p.12315-12323

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

The androgen receptor (AR) antagonist enzalutamide is one of the principal treatments for men with castration-resistant prostate cancer (CRPC). However, not all patients respond, and resistance mechanisms are largely unknown. We hypothesized that genomic and transcriptional features from metastatic CRPC biopsies prior to treatment would be predicti...

Alternative Titles

Full title

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7275746

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7275746

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1922207117

How to access this item